(1S,3R)-Dihydroxy-(20S)-[(5'S)-(2''-hydroxy-2''-propyl)-(2'R)-tetrahydrofuryl]-22,23,24,25,26,27-hexanor-1alpha-hydroxyvitamin D3

ID: ALA4066758

Chembl Id: CHEMBL4066758

PubChem CID: 132274116

Max Phase: Preclinical

Molecular Formula: C28H44O4

Molecular Weight: 444.66

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)[C@H]4CC[C@@H](C(C)(C)O)O4)CC[C@@H]23)C[C@@H](O)C[C@H]1O

Standard InChI:  InChI=1S/C28H44O4/c1-17-20(15-21(29)16-24(17)30)9-8-19-7-6-14-28(5)22(10-11-23(19)28)18(2)25-12-13-26(32-25)27(3,4)31/h8-9,18,21-26,29-31H,1,6-7,10-16H2,2-5H3/b19-8+,20-9-/t18-,21+,22+,23-,24+,25+,26-,28+/m0/s1

Standard InChI Key:  DDIWZQGTNVZJGO-AOWJSLKNSA-N

Alternative Forms

  1. Parent:

    ALA4066758

    ---

Associated Targets(Human)

VDR Tclin Vitamin D receptor (26531 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

vdra Vitamin D3 receptor A (38 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 444.66Molecular Weight (Monoisotopic): 444.3240AlogP: 5.08#Rotatable Bonds: 4
Polar Surface Area: 69.92Molecular Species: NEUTRALHBA: 4HBD: 3
#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 3#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: CX LogP: 3.57CX LogD: 3.57
Aromatic Rings: Heavy Atoms: 32QED Weighted: 0.57Np Likeness Score: 3.02

References

1. Belorusova AY, Martínez A, Gándara Z, Gómez G, Fall Y, Rochel N..  (2017)  Structure-activity relationship study of vitamin D analogs with oxolane group in their side chain.,  134  [PMID:28399453] [10.1016/j.ejmech.2017.03.081]

Source